Brenntag SE stock downgraded to 'Underperform' amid weak demand and rising costs
Brenntag SE, a global leader in chemical distribution, is facing fresh challenges as its stock was downgraded to 'Underperform'. The company's latest quarterly results reveal ongoing struggles with weak demand and rising costs. Despite this, shares edged slightly higher on Friday, March 13, 2026, closing at €49.20—up 0.24% for the day.
The downgrade came from Jefferies, which set a price target of €42, suggesting a potential 15% decline. Deutsche Bank and Warburg Research have also lowered their ratings to 'Hold', reflecting broader concerns. Analysts point to sluggish demand, particularly in automotive and construction markets, as a key issue for the entire chemical distribution sector.
Brenntag's business model, which relies on price fluctuations in chemicals, has helped it expand market share through acquisitions. However, organic growth remains weak. The company's margins continue to suffer due to climbing input costs and tepid demand. While some modest volume growth is expected in 2026—driven by specialty chemicals—this has not yet offset wider pressures. Since the downgrade, Brenntag's stock has shown little movement. After closing at €49.20 on March 13, it traded around the same level on March 15, up just 0.2% intraday. Earlier in March, shares had dipped to a four-week low, fluctuating between €47.63 and €48.95.
The downgrades and weak market conditions highlight the difficulties Brenntag SE currently faces. With demand remaining soft and costs rising, the company's ability to sustain growth will depend on its specialty chemicals segment and further strategic moves. For now, investors appear cautious, as reflected in the stock's subdued performance.
